Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Afton Pharma is an India-based pharmaceutical manufacturer, exporter, and trader focused primarily on active pharmaceutical ingredients and certain finished formulations. The company presents itself as an integrated supplier spanning APIs to formulations, with offerings that include chlorhexidine products, pregabalin, phenylbutazone, atorvastatin calcium, duloxetine hydrochloride, febuxostat, and a broader catalog of small-molecule APIs. Its website emphasizes GMP- and regulatory-norm-based processing, in-house laboratory capabilities, quality control, and support for domestic and export customers. Afton Pharma appears to operate as a commercial-stage supplier rather than a drug-discovery biotech, with business centered on manufacturing, distribution, and export of pharmaceutical ingredients and related products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Afton Pharma.